Literature DB >> 2987102

Lung cancer heterogeneity: a blinded and randomized study of 100 consecutive cases.

V L Roggli, R T Vollmer, S D Greenberg, M H McGavran, H J Spjut, R Yesner.   

Abstract

The heterogeneity of lung carcinomas was recognized in the past, but few previous studies attempted to quantitate this heterogeneity. In the present study 100 consecutive cases of lung carcinoma (65 surgical resections and 35 autopsies) were collected, and either the entire tumor or ten blocks were examined in a blinded and randomized fashion using the revised (1981) WHO classification. At least three of five panelists agreed on the major histologic type present for 94 per cent of the slides. Agreement for the diagnosis of small cell carcinomas (at least four of five observers) was 98 per cent, but only 72 per cent agreement was attained for the subtyping of small cell carcinomas (e.g., oat cell versus intermediate). Only 34 per cent of the cases were homogeneous according to the majority of the panelists. An additional 21 per cent of the cases showed minor (subtype) heterogeneity (e.g., mixtures of acinar and papillary patterns in adenocarcinoma). Forty-five per cent of the cases showed major heterogeneity, i.e., at least one slide from the case showed a major histologic type different from that of the remainder. Seven small cell carcinomas were homogeneous, whereas in eight cases mixtures of small cell and other cell types were seen. In all but one of the cases involving bronchioloalveolar cell patterns, other patterns of adenocarcinoma were present elsewhere in the tumor. In all six cases involving giant cell carcinoma patterns, adenocarcinoma patterns were also present in some sections. Heterogeneity was identified by extensive sampling of the entire tumor and was seldom recognized in biopsy specimens.

Entities:  

Mesh:

Year:  1985        PMID: 2987102     DOI: 10.1016/s0046-8177(85)80106-4

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  28 in total

Review 1.  Acquisition and processing of endobronchial ultrasound-guided transbronchial needle aspiration specimens in the era of targeted lung cancer chemotherapy.

Authors:  William Bulman; Anjali Saqi; Charles A Powell
Journal:  Am J Respir Crit Care Med       Date:  2011-10-27       Impact factor: 21.405

2.  Observer variability in histopathological reporting of non-small cell lung carcinoma on bronchial biopsy specimens.

Authors:  R A Burnett; S R Howatson; S Lang; F D Lee; A M Lessells; K M McLaren; E R Nairn; S Ogston; A J Robertson; J G Simpson; G D Smith; H B Tavadia; F Walker
Journal:  J Clin Pathol       Date:  1996-02       Impact factor: 3.411

3.  Is the incidence of primary adenocarcinoma of the lung increasing?

Authors:  C J Caldwell; C L Berry
Journal:  Virchows Arch       Date:  1996-12       Impact factor: 4.064

4.  Small cell and squamous cell lung carcinomas: sequential occurrence at a single site.

Authors:  C P Kelly; D O'Donnell; B West; N Gallagher; L Clancy
Journal:  Thorax       Date:  1987-10       Impact factor: 9.139

5.  Multi-objective Parameter Auto-tuning for Tissue Image Segmentation Workflows.

Authors:  Luis F R Taveira; Tahsin Kurc; Alba C M A Melo; Jun Kong; Erich Bremer; Joel H Saltz; George Teodoro
Journal:  J Digit Imaging       Date:  2019-06       Impact factor: 4.056

6.  Reproducibility of histopathological subtypes and invasion in pulmonary adenocarcinoma. An international interobserver study.

Authors:  Erik Thunnissen; Mary Beth Beasley; Alain C Borczuk; Elisabeth Brambilla; Lucian R Chirieac; Sanja Dacic; Douglas Flieder; Adi Gazdar; Kim Geisinger; Philip Hasleton; Yuichi Ishikawa; Keith M Kerr; Sylvie Lantejoul; Yoshiro Matsuno; Yuko Minami; Andre L Moreira; Noriko Motoi; Andrew G Nicholson; Masayuki Noguchi; Daisuke Nonaka; Giuseppe Pelosi; Iver Petersen; Natasha Rekhtman; Victor Roggli; William D Travis; Ming S Tsao; Ignacio Wistuba; Haodong Xu; Yasushi Yatabe; Maureen Zakowski; Birgit Witte; Dirk Joop Kuik
Journal:  Mod Pathol       Date:  2012-07-20       Impact factor: 7.842

7.  How reliable is the diagnosis of lung cancer using small biopsy specimens? Report of a UKCCCR Lung Cancer Working Party.

Authors:  J S Thomas; D Lamb; T Ashcroft; B Corrin; C W Edwards; A R Gibbs; W E Kenyon; R J Stephens; W F Whimster
Journal:  Thorax       Date:  1993-11       Impact factor: 9.139

8.  Observer variability in histopathological reporting of malignant bronchial biopsy specimens.

Authors:  R A Burnett; J Swanson Beck; S R Howatson; F D Lee; A M Lessells; K M McLaren; S Ogston; A J Robertson; J G Simpson; G D Smith
Journal:  J Clin Pathol       Date:  1994-08       Impact factor: 3.411

9.  Correlation of immunohistochemical staining p63 and TTF-1 with EGFR and K-ras mutational spectrum and diagnostic reproducibility in non small cell lung carcinoma.

Authors:  Erik Thunnissen; Evan Boers; Daniëlle A M Heideman; Katrien Grünberg; Dirk J Kuik; Arnold Noorduin; Matthijs van Oosterhout; Divera Pronk; Cees Seldenrijk; Hannie Sietsma; Egbert F Smit; Robertjan van Suylen; Jan von der Thusen; Bart Vrugt; Anne Wiersma; Birgit I Witte; Michael den Bakker
Journal:  Virchows Arch       Date:  2012-10-12       Impact factor: 4.064

10.  Unusual presentation of an uncommon lung malignancy.

Authors:  K Ramaraju; B Aggarwal; R Kulsrestha; Sk Chhabra
Journal:  Lung India       Date:  2008-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.